CIMDUO

Peak

lamivudine and tenofovir disoproxil fumarate

Viatris (2)
NDAORALTABLETPriority Review
Approved
Feb 2018
Lifecycle
Peak
Competitive Pressure
30/100

Mechanism of Action

Nucleoside Reverse Transcriptase Inhibitors

Pharmacologic Class:

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Indications (1)

combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult
Company
Viatris (2)
Viatris (2)
China - Shanghai
292 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers